RPE65
Retinoid isomerohydrolase
Also known as: BCO3, LCA2, rd12, RP20, RPE65_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16518
- Gene
- RPE65
- Ensembl
- ENSG00000116745
- Chromosome
- 1
- Canonical length
- 533 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is a component of the vitamin A visual cycle of the retina which supplies the 11-cis retinal chromophore of the photoreceptors opsin visual pigments. It is a member of the carotenoid cleavage oxygenase superfamily. All members of this superfamily are non-heme iron oxygenases with a seven-bladed propeller fold and oxidatively cleave carotenoid carbon:carbon double bonds. However, the protein encoded by this gene has acquired a divergent function that involves the concerted O-alkyl ester cleavage of its all-trans retinyl ester substrate and all-trans to 11-cis double bond isomerization of the retinyl moiety. As such, it performs the essential enzymatic isomerization step in the synthesis of 11-cis retinal. Mutations in this gene are associated with early-onset severe blinding disorders such as Leber congenital. [provided by RefSeq, Oct 2017]
Canonical amino-acid sequenceUniProt
533 residues, UniProt reviewed canonical sequence.
>Q16518|RPE65
1 MSIQVEHPAG GYKKLFETVE ELSSPLTAHV TGRIPLWLTG SLLRCGPGLF EVGSEPFYHL
61 FDGQALLHKF DFKEGHVTYH RRFIRTDAYV RAMTEKRIVI TEFGTCAFPD PCKNIFSRFF
121 SYFRGVEVTD NALVNVYPVG EDYYACTETN FITKINPETL ETIKQVDLCN YVSVNGATAH
181 PHIENDGTVY NIGNCFGKNF SIAYNIVKIP PLQADKEDPI SKSEIVVQFP CSDRFKPSYV
241 HSFGLTPNYI VFVETPVKIN LFKFLSSWSL WGANYMDCFE SNETMGVWLH IADKKRKKYL
301 NNKYRTSPFN LFHHINTYED NGFLIVDLCC WKGFEFVYNY LYLANLRENW EEVKKNARKA
361 PQPEVRRYVL PLNIDKADTG KNLVTLPNTT ATAILCSDET IWLEPEVLFS GPRQAFEFPQ
421 INYQKYCGKP YTYAYGLGLN HFVPDRLCKL NVKTKETWVW QEPDSYPSEP IFVSHPDALE
481 EDDGVVLSVV VSPGAGQKPA YLLILNAKDL SEVARAEVEI NIPVTFHGLF KKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPE65 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 7.8 nTPM
Expression across tissuesHPA
Tissue
- retina: 7.8 nTPM
- midbrain: 5.2 nTPM
- seminal vesicle: 4.2 nTPM
- choroid plexus: 3.5 nTPM
- hypothalamus: 3.3 nTPM
- prostate: 1.7 nTPM
Single-cell type
- retinal pigment epithelial cells: 7,170 nCPM
- rod photoreceptor cells: 48 nCPM
- ependymal cells: 33 nCPM
- choroid plexus epithelial cells: 16 nCPM
- astrocytes: 13 nCPM
- cone photoreceptor cells: 12 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 11 nTPM
- choroid plexus: 10 nTPM
- thalamus: 9.1 nTPM
- hypothalamus: 6.7 nTPM
- medulla oblongata: 4.6 nTPM
- spinal cord: 3.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RPE65.
Disease | AllUniProt
Conditions RPE65 is implicated in, by any mechanism.
- Leber congenital amaurosis 2 (LCA2) MIM:204100
- Retinitis pigmentosa 20 (RP20) MIM:613794
- Retinitis pigmentosa 87 with choroidal involvement (RP87) MIM:618697
Disease | GeneticClinVar
332 pathogenic / likely-pathogenic of 1,144 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Leber congenital amaurosis 2
- Retinitis pigmentosa 20
- RPE65-related recessive retinopathy
- Leber congenital amaurosis
- Retinitis pigmentosa 87 with choroidal involvement
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- circadian rhythm
- detection of light stimulus involved in visual perception
- neural retina development
- retina homeostasis
- retinal metabolic process
- retinoid metabolic process
- visual perception
- vitamin A metabolic process
- zeaxanthin biosynthetic process
Molecular functions
- beta-carotene 15,15'-dioxygenase activity
- cardiolipin binding
- isomerase activity
- metal ion binding
- phosphatidylcholine binding
- phosphatidylserine binding
- retinol isomerase activity
- all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity
- all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPE65 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPE65 as an antibody target. Whether an autoantibody or antibody against RPE65 could matter depends on whether native RPE65 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPE65 is annotated at the cell surface, where native RPE65 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RPE65 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...